Riskpilot← Back to searchSign inGet full accessBobolina AB
ABActiveOrg 5593286551Åkervägen 14General medical practice activities · NACE 8621Est. 20212 employees
Revenue 2025
SEK 1,9M
-17% vs 2024
EBITDA margin
33.2%
-26% vs 2024
Equity ratio
56.9%
Financial strength
Net profit 2025
SEK 476K
-22% vs 2024
| Revenue | SEK 1,9M | -17% |
| EBITDA | SEK 642K | -26% |
| Net profit | SEK 476K | -22% |
| Total assets | SEK 2,2M | -5% |
| Equity | SEK 1,3M | +12% |
| Employees | 2 | — |
Legal name
Bobolina AB
Org number
5593286551
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 juli 2021
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Sjukvård, läkarverksamhet, utbildning och undervisning samt därmed förenligt verksamhet
Address
Åkervägen 14
Email
munira.alsaadi@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 316 | 1 316 | 2 135 | 2 330 | 1 936 |
| Staff expenses | — | −237 | −1 283 | — | −1 146 |
| EBITDA | 1 039 | 1 039 | 788 | 873 | 642 |
| Depreciation & amort. | −0 | −0 | — | −122 | −163 |
| EBIT | 1 039 | 1 039 | 788 | 751 | 479 |
| Net financials | — | −0 | 3 | 178 | 226 |
| Profit before tax | 783 | 784 | 596 | 734 | 564 |
| Tax | −161 | 161 | −124 | −121 | −87 |
| Net profit | 622 | 622 | 471 | 613 | 476 |
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 272 | 1 272 | 2 169 | 2 342 | 2 222 |
| Equity | 647 | 647 | 1 119 | 1 129 | 1 263 |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 370 | 370 | 600 | 567 | 172 |
| Total debt | 370 | 370 | 600 | 567 | 172 |
EBITDA margin
33.2%
This company
15.8%
Market median
+110% vs market
20222025
Equity ratio
56.9%
This company
38.2%
Market median
+49% vs market
20222025
Return on equity
37.7%
This company
18.4%
Market median
+105% vs market
20222025
Net profit margin
24.6%
This company
8.1%
Market median
+204% vs market
20222025
Asset turnover
0.87×
This company
1.12×
Market median
+22% vs market
20222025
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-23 – 2022-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-05-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
ML | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bobolina AB 
Sundets medical ABBoard members of Bobolina AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Lage Ronny Gummesson | Audit | 0 companies |
| Munira Fadil Al-Saadi | Board of Directors | 0 companies |
| Handrin Karim Abdulhadi | Deputy Board Member | 0 companies |